Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat

Area of Science:

• Neuroendocrinology
• Pharmacology

Background:

• The hypothalamic-pituitary-adrenocortical (HPA) axis is a key stress response system.
• Opioid receptors play a complex role in regulating physiological responses, including stress.

Purpose of the Study:

• To investigate the involvement of multiple opioid receptor subtypes in modulating the HPA axis during stress.
• To characterize the effects of various opioid agonists and antagonists on plasma corticosterone levels.

Main Methods:

• Systemic administration of selective kappa, mu, and delta opioid agonists and antagonists in male rats.
• Measurement of plasma corticosterone and adrenocorticotropin levels via radioimmunoassay.
• Experiments included tolerant animals and hypophysectomized/adrenalectomized rats.

Main Results:

• Kappa opioid agonists (e.g., ethylketocyclazocine, U50488H) produced potent, dose-dependent increases in corticosterone.
• These effects were reversed by naloxone and Win 44441-3, indicating opioid receptor involvement.
• Mu and delta opioid agonists also increased corticosterone, suggesting broader opioid system influence.
• Tolerance to morphine did not attenuate the kappa agonist response, but tolerance to kappa agonists did.
• Agonist/antagonists like butorphanol and cyclazocine mimicked kappa agonists.

Conclusions:

• Kappa opioid receptors are potent activators of the HPA axis.
• Mu and delta opioid receptors also contribute to HPA axis regulation.
• Opioid receptor interactions and tolerance significantly influence the stress response pathway.